Evidence of Mycobacterial Disease in Chronic Obstructive Pulmonary Disease Patients, the importance of Histological Assessment

Authors

  • Nighat Ara Department of Anatomy, Nowshera Medical College, Nowshera - Pakistan
  • Zahid Sarfaraz Khan Department of Anatomy, Khyber Girls Medical College, Peshawar - Pakistan
  • Shaista Alam Department of Microbiology, Pak International Medical College, Peshawar - Pakistan
  • Mohsina Haq Department of Pathology, Peshawar Medical and Dental College, Riphah University, Islamabad - Pakistan
  • Muhammad Abbas Department of Medicine, Peshawar Medical College, Prime Teaching Hospital, Peshawar - Pakistan
  • Salman Khan Department of Medicine, Gomal Medical College, Dera Ismail Khan - Pakistan

Keywords:

Chronic Obstructive Pulmonary Disease, Non-Tuberculous Mycobacteria, Histological Assessment, Bronchiectasis

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a prevalent respiratory condition often exacerbated by bacterial infections. However, atypical mycobacteria, which are opportunistic pathogens, can also significantly contribute to COPD exacerbations, particularly in individuals with pre-existing lung damage. Objective: To investigate the role of non-tuberculous mycobacteria (NTM) in COPD exacerbations and emphasize the importance of histological assessment in detecting and characterizing these infections. Methodology: The study employed a prospective cohort design involving 112 patients with chronic respiratory conditions. Comprehensive demographic and clinical data were collected, including occupational history and lifestyle factors. The diagnosis of NTM pulmonary disease adhered to American Thoracic Society guidelines, incorporating symptom assessment, imaging, and sputum cultures. Histopathological evaluation of lung tissue from bronchial lavage was performed to assess bronchiolectasis and inflammation. Standardized data collection and management ensured accuracy, and regular follow-ups were conducted to monitor disease progression and treatment outcomes. Results: The study on COPD patients with non-tuberculous mycobacterial infections involved 112 participants, including 69 males (61.98%) and 43 females (38.02%). Histopathological findings included bronchiolar inflammation in 62 patients (55.36%), bronchiolectasis in 54 patients (48.21%), peribronchiolar inflammation in 47 patients (41.96%), and granuloma formation in 33 patients (29.46%). Regarding treatment outcomes, 40 patients (35.71%) improved, 46 patients (41.07%) remained stable, and 26 patients (23.21%) worsened. Chi-square tests showed significant associations between NTM infections and persistent cough (χ² = 12.34, p = 0.0004), hemoptysis (χ² = 7.89, p = 0.0050), chest pain (χ² = 15.76, p < 0.0001), and dyspnea (χ² = 14.32, p = 0.0002). Conclusion: This study highlights the crucial role of histological assessment in accurately diagnosing and understanding non-tuberculous mycobacterial infections in COPD patients, emphasizing its impact on effective disease management.

References

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195:557–82. DOI: 10.1164/rccm.201701-0218PP.

Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. The Lancet. 2007;370:786–96. DOI: 10.1016/S0140-6736(07)61382-8.

Sapey E. COPD exacerbations {middle dot} 2: Aetiology. Thorax. 2006;61:250–8. DOI: 10.1136/thx.2005.041822.

Glassroth J. Pulmonary Disease Due to Nontuberculous Mycobacteria. Chest. 2008;133:243–51. DOI: 10.1378/chest.07-0358.

Patel AK. Sputum Bacteriology and Antibiotic Sensitivity Pattern of Patients Having Acute Exacerbation of COPD in India – A Preliminary Study. J Pulm Respir Med. 2015;05. DOI: 10.4172/2161-105X.1000238.

Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Euro Resp J. 2008;31:1322–33. DOI: 10.1183/09031936.00140007.

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med. 2007;175:367–416. DOI: 10.1164/rccm.200604-571ST.

Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax. 2000;55:210–8. DOI: 10.1136/thorax.55.3.210.

Cowman S, Wilson R, Loebinger MR. Opportunistic mycobacterial diseases. Medicine. 2012;40:346–8. DOI: 10.1016/j.mpmed.2012.03.008.

Marusic A, Katalinic-Jankovic V, Popovic-Grle S, Jankovic M, Mazuranic I, Puljic I, et al. Mycobacterium xenopi pulmonary disease – Epidemiology and clinical features in non-immunocompromised patients. J Inf. 2009;58:108–12. DOI: 10.1016/j.jinf.2009.01.001.

Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, et al. High-Resolution CT Findings of Mycobacterium avium-intracellulare Complex Pulmonary Disease: Correlation with Pulmonary Function Test Results. Am J Roentgenol. 2008;191:W160–6. DOI: 10.2214/AJR.07.3505.

Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS, Kwon OJ. Nontuberculous Mycobacterial Pulmonary Infection in Immunocompetent Patients: Comparison of Thin-Section CT and Histopathologic Findings. Radiol. 2004;231:880–6. DOI: 10.1148/radiol.2313030833.

Fjallbrant H, Akerstrom M, Svensson E, Andersson E. Hot tub lung: an occupational hazard. Eur Respir J. 2013;22:88–90. DOI: 10.1183/09059180.00002312.

Hansell DM, Wells AU, Padley SP, Muller NL. Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiol. 1996;199:123–8. DOI: 10.1148/radiology.199.1.8633133.

Selman-Lama M, Perez-Padilla R. Airflow obstruction and airway lesions in hypersensitivity pneumonitis. Clin Chest Med. 1993;14:699–714. DOI: 10.1016/S0272-5231(21)00933-3.

Petersen H, Sood A, Meek PM, Shen X, Cheng Y, Belinsky SA, et al. Rapid Lung Function Decline in Smokers Is a Risk Factor for COPD and Is Attenuated by Angiotensin-Converting Enzyme Inhibitor Use. Chest. 2014;145:695–703. DOI: 10.1378/chest.13-0799.

Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68:256–62. DOI: 10.1136/thoraxjnl-2012-201772.

Andrejak C, Thomsen VO, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous Pulmonary Mycobacteriosis in Denmark. Am J Respir Crit Care Med. 2010;181:514–21. DOI: 10.1164/rccm.200905-0778OC.

Char A, Hopkinson NS, Hansell DM, Nicholson AG, Shaw EC, Clark SJ, et al. Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study. BMC Pulm Med. 2014;14:124. DOI: 10.1186/1471-2466-14-124.

Larsson LO, Polverino E, Hoefsloot W, Codecasa LR, Diel R, Jenkins SG, Loebinger MR. Pulmonary disease by non-tuberculous mycobacteria–clinical management, unmet needs and future perspectives. Expert Rev Respir Med. 2017;11(12):977-89. DOI: 10.1080/17476348.2017.1386563

Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, et al. Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection. An NTM Research Consortium Workshop Report. Ann Am Thorac Soc. 2016;13(9):S379-84. DOI: 10.1513/AnnalsATS.201605-387WS.

Char A, Hopkinson NS, Hansell DM, Nicholson AG, Shaw EC, Clark SJ, et al. Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study. BMC Pulm Med. 2014;14:1-7. DOI: 10.1186/1471-2466-14-124.

Dettmer S, Ringshausen FC, Fuge J, Maske HL, Welte T, Wacker F, et al. Computed tomography in adults with bronchiectasis and nontuberculous mycobacterial pulmonary disease: typical imaging findings. J Clin Med. 2021;10(12):2736. DOI: 10.3390/jcm10122736.

Lipman M, Cleverley J, Fardon T, Musaddaq B, Peckham D, van der Laan R, Whitaker P, White J. Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. BMJ Open Respir Res. 2020;7(1):e000591. DOI: 10.1136/bmjresp-2020-000591.

Ali J. A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective. Expert Rev Respir Med. 2021;15(5):663-73. DOI: 10.1080/17476348.2021.1887734.

Van Ingen J, Aksamit T, Andrejak C, Bottger EC, Cambau E, Daley CL, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51(3). DOI: 10.1183/13993003.00170-2018.

Downloads

Published

2022-03-02

How to Cite

Ara, N. ., Khan, Z. S. ., Alam, S. ., Haq, M. ., Abbas, M. ., & Khan, S. . (2022). Evidence of Mycobacterial Disease in Chronic Obstructive Pulmonary Disease Patients, the importance of Histological Assessment. Pakistan Journal of Chest Medicine, 28(1), 95–102. Retrieved from https://www.pjcm.net/index.php/pjcm/article/view/856

Issue

Section

Original Article

Most read articles by the same author(s)